These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 23967867

  • 1. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
    Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L.
    J Transl Med; 2013 Aug 22; 11():195. PubMed ID: 23967867
    [Abstract] [Full Text] [Related]

  • 2. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma.
    Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT.
    Carcinogenesis; 2012 May 22; 33(5):1113-20. PubMed ID: 22362728
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
    Chen P, Zhao X, Ma L.
    Mol Cell Biochem; 2013 Nov 22; 383(1-2):49-58. PubMed ID: 23842624
    [Abstract] [Full Text] [Related]

  • 4. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, Li L, Ren S, Zhang M, Xu M.
    J Exp Clin Cancer Res; 2019 Feb 22; 38(1):98. PubMed ID: 30795787
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
    Yang H, Zheng W, Shuai X, Chang RM, Yu L, Fang F, Yang LY.
    Oncotarget; 2015 Sep 29; 6(29):27736-50. PubMed ID: 26315541
    [Abstract] [Full Text] [Related]

  • 6. miR-363 inhibits the growth, migration and invasion of hepatocellular carcinoma cells by regulating E2F3.
    Ye J, Zhang W, Liu S, Liu Y, Liu K.
    Oncol Rep; 2017 Dec 29; 38(6):3677-3684. PubMed ID: 29039555
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z, Xia X, Lu J.
    Med Sci Monit; 2020 Jan 19; 26():e919241. PubMed ID: 31955177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L, Guan H, Gu C, Cao Y, Shao J, Wang F.
    Tumour Biol; 2016 Feb 19; 37(2):2497-507. PubMed ID: 26385772
    [Abstract] [Full Text] [Related]

  • 11. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
    Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW.
    Exp Mol Med; 2013 Jan 10; 45(1):e3. PubMed ID: 23306701
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73.
    Zhao J, Xu T, Wang F, Cai W, Chen L.
    Biomed Pharmacother; 2017 Jun 10; 90():744-751. PubMed ID: 28419971
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.